Skip to main content
logo
ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
16.09
-0.37 (-2.25%)
At close: Oct 13, 2026, 4:00 PM EDT
16.37
+0.28 (1.74%)
After-hours: Oct 13, 2026, 7:40 PM EDT

ArriVent BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
793831898---
Market Cap Growth
-6.25%-7.48%----
Enterprise Value
421530615---
Last Close Price
16.4620.1226.64---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.172.703.48---
P/TBV Ratio
2.162.703.48---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.0000.000.000.00-
Net Debt / Equity Ratio
-1.02-1.02-0.85-0.99-0.94-0.90
Quick Ratio
13.4012.0612.7013.0019.6020.64
Current Ratio
14.1612.8313.1413.7621.8523.63
Return on Equity (ROE)
-53.25%-58.88%-39.36%-42.57%-34.22%-
Return on Assets (ROA)
-33.11%-36.49%-26.91%-26.95%-20.42%-
Return on Capital Employed (ROCE)
-48.00%-57.80%-36.60%-49.20%-21.20%-28.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-20.72%-20.02%-8.97%---
Buyback Yield / Dilution
-30.39%-22.22%-1369.88%-67.64%-79.57%-
SEC Filings: 10-K · 10-Q